OUHSC Research News – Monday, March 14, 2022
Notices and Reminders
Announcement: Interim Vice President of Research
Mary Beth Humphrey, M.D., Ph.D. will serve as Interim Vice President of Research at the OU Health Sciences Center. Dr. Humphrey has been a faculty member in the OU College of Medicine for the past 16 years, and three years ago, she was named the college’s Associate Dean for Research. This role, in addition to her own active research focus, gives her a unique perspective and understanding of research needs on campus. At the OU Health Sciences Center, Dr. Humphrey’s insight has been a valuable asset in her service on a number of administrative committees, and she will continue to serve as chair of the Research Strategic Plan Oversight Committee. In her role as Interim Vice President of Research, she will initially focus on the development and implementation of the HSC Strategic Plan – specifically with regard to research – with the ultimate goal of making HSC a top-tier research-driven academic health center.
She earned her M.D. and Ph.D. at Baylor College of Medicine in Houston before completing her internal medicine internship, residency, chief residency, and rheumatology fellowship at the University of California San Francisco. Dr. Humphrey is an internationally renowned scholar in the field of osteoimmunology and osteoporosis, focusing on interactions of the bone microenvironment with the immune system. Her impactful body of research has maintained consistent NIH funding since she joined the OU faculty, having received $10 million in grants. She has an active laboratory, which focuses on understanding the role of myeloid cells in human diseases, including osteoporosis, osteoarthritis, heart failure with preserved ejection fraction, and Alzheimer’s disease.
ORA reminder: Each senior/key personnel must electronically sign their respective NIH Other Support form. The version with the original electronic signature will need to be retained by the department, to be made available to NIH and/or ORA upon request. ORA will only keep the final flattened versions on file as part of the submission package and cannot serve as the central repository for the original signed copies of the Other Support.
ORA reminder: All research, training, professional, provider, public service, and clinical trial contracts, or any terms and conditions involved in the award document MUST be routed through ORA for legal, fiscal, and administrative review by an authorized agent of the Board of Regents of the University of Oklahoma in ORA. Individual faculty members are NOT authorized representatives of the University and may not negotiate or sign contracts or any award terms or conditions on behalf of the University.
NIH Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
Description: The participating NIH Institutes and Centers will supplement the existing awards of scientists who have demonstrated a commitment to exceptional training and mentorship, especially to individuals from groups identified as underrepresented in the biomedical sciences.
Supplements are available for various grant types, including career development, training, cooperative, and Research Project Grants (R01). They will provide up to $250,000 in direct costs, not to exceed the direct costs of the parent award. Investigators may use the funds to perform additional research within the parent grant’s scope, develop curricula or training activities to strengthen mentor training, or help foster the research career development of additional students, post-doctorates, or other trainees.
Application deadline: April 07, 2022
Link to Full Announcement: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-057.html
Workshops and Seminars
Save the Date - ORA Noon Conference offered via Zoom
Date: March 30, 2022 at 1:00 pm
Topic: Writing the Abstract
Description: The abstract is often considered the most important piece of a peer-reviewed manuscript. Abstracts provide an overview of your research study and help readers decide whether to read the full manuscript. This presentation introduces types of abstracts; discusses a systematic approach to writing; reviews the APA journal article reporting standards for quantitative, qualitative, and mixed-methods abstracts; and provides resources and guidelines for writing your own abstract.
2022 Cystic Fibrosis Foundation Research Conference
2022 CF Foundation Research Conference will be held June 26 – 30, 2022. This conference is directed towards basic and clinical researchers and trainees and industry representatives with a goal of bridging advances in basic discovery with therapeutic development. To foster a highly interactive environment, attendance will be limited. Applicants who submit relevant abstracts will be prioritized. The application portal will be open March 7 – 24, 2022. More information: https://www.surveymonkey.com/r/2022ResearchConferenceRegPortal.
OUHSC Funding Opportunities
Presbyterian Health Foundation Research Grants Program - 2022
Deadline: various -please see the table below
Description: This grant program funds multiple types of projects and has enabled the progression of pioneering concepts to research studies, the establishment of renowned clinicians and basic scientists transdisciplinary teams unifying a broad range of expertise and skills, the development of extremely talented junior faculty, the provision of infrastructure support for faculty to continue ground-breaking research, and more.
Click here to learn more about the 2022 opportunities.
If you have any questions, please email ORA4PHF@ouhsc.edu.
Link to Full Announcement: https://research.ouhsc.edu/Resources/PHF-Funding-2022
March 25, 2022
April 1, 2022
IBEST-OUHSC Funding for Interdisciplinary Research (IBEST-OUHSC)
Description: The University of Oklahoma Institute for Biomedical Engineering, Science, and Technology (IBEST) in partnership with the University of Oklahoma Health Sciences Center (OUHSC) invites faculty who are members of Norman Campus and OUHSC to submit applications for grant funding to support research activities in the areas of healthcare, in particular to promote the integration of engineering principles and innovations with both applied and fundamental medical and clinical research, as well as to facilitate the creation of multi-disciplinary teams. This program should provide the preliminary data needed for submission of a large, multi-PI proposal to be submitted for external funding at a national agency following the award.
Application Submission Deadline: March 18, 2022
Link to Full Announcement: Please refer to the attached flyers for application forms and guidelines.
Questions: Dr. Darrin R. Akins, email@example.com
OUHSC GeroScience T32 is accepting applications for Post-Doctoral Fellows & Graduate Students to Appoint May 1st, 2022
Purpose: Goal of the GeroScience T32 is to offer training and mentorship to young investigators, both Graduate Students and Post-Doctoral Fellows interested in aging research and assist them in securing independent funding. Current trainees must reapply.
- Must be a US citizen or permanent resident (green card holder)
- Project must be designed to address aging and age-related disease.
- Students must have successfully completed the PH.D. qualifying examination
Application Submission Deadline: APRIL 1, 2022
Link to Full Announcement: Please refer to the attached flyer.
Call for Nominations: The Scott McMeekin MD Cancer Research Award
Description: The Scott McMeekin MD Cancer Research Award is an annual award that is given to Stephenson Cancer Center member whose accomplishments in cancer research/scholarly productivity are exceptional and clearly exceed normal expectations and are highlighted by high-impact, peer-reviewed publications, and receipt of significant cancer research funding. Nominations are to be submitted electronically to Gina-Serrano@ouhsc.edu no later than 5pm on March 15th for consideration.
Link to Full Announcement: Please review the attached for criteria, eligibility, and nomination requirements.
Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email firstname.lastname@example.org or email@example.com).
- A European cellular agriculture company (requested anonymity) interested development of cultivated dairy products is seeking a collaboration for improving fermentation of filamentous fungal strains. Of particular interest is submerged, solid-state or semi-solid-state fermentation methods for the production of fats and recombinant proteins. Out of scope: methods requiring animal-derived ingredients. Submission entails a 1-pg non-confidential summary of technology (deadline 3/18)
- BioMarin Pharmaceutical Inc. is seeking early research and preclinical proposals for C-type natriuretic peptide (CNP) with application in hematological disease and genetic diseases of the musculoskeletal, cardiovascular, and central nervous systems. Targeted cells/tissues should express NPRB and demonstrate evidence of MAP kinase pathway involvement or cGMP deficiency in disease pathogenesis. Out of scope: approaches that require modification to CNP. Submission entails a 1-pg non-confidential summary of technology (deadline 4/1)
- A global leader in the refractory industry, RHI Magnesita, is looking to develop or match a green process to convert carbon bonded secondary refractory raw materials into usable materials. Of specific interest is recycling of materials and removal of components (i.e. carbon) from bricks using cost-effective processes and methods that can be inserted along the recycling process. Submission entails a 1-pg non-confidential summary of technology (deadline 4/1)
- A global pharmaceutical company (requested anonymity) is seeking research related to generation of T cells, both alpha beta and gamma delta, from induced pluripotent stem cells (iPSC’s) for therapeutic uses. Out of scope: NK cell focused research (other than intermediate NKT’s). Submission entails a 1-pg non-confidential summary of technology (deadline 4/8)
Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit
Description: Grant proposals are being accepted from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $100,000 for IITs and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Submission Checklist provided with this notice.
Application Submission Deadline: April 4, 2022
Link to Full Announcement: Please refer to the attached flyer
College of Medicine Alumni Association (COMAA) Research Program
Description: Proposals are being accepted from full time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund. COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early stage investigators in the College of Medicine. The guidelines are included with this notice.
NOTE: All applications MUST be routed through the Office of Research Administration (ORA) and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official.
Application Submission Deadline: April 15, 2022
Link to Full Announcement: Please refer to the attached flyers.
New Clinical Study Opportunities
**Please note this is NOT a solicitation for study subjects**
Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:
- 213749 GlaxoSmithKline Biologicals SA HPV prevention
- TAK-330-3001 A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial with Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of PROTHROMPLEX TOTAL for the Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation in Patients Requiring Urgent Surgery/Invasive Procedure
- LOXO-BTK-20030 Loxo Oncology_CLL and SLL
- ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
- Pfizer Global Medical Grants Announces a New Education RFP in Renal Cell Carcinoma
- Projects that will be considered for Pfizer support will focus only on two areas:
- Nursing or pharmacist education programs or resources that nurses or pharmacists can use as they care for patients with RCC
- Patient education programs or resources that patients can use as they make decisions about their own care and treatment
- Neurocrine Biosciences, Inc. Phase 3 study to evaluate the efficacy, safety, and tolerability of Valbenazine (NBI-98854) administered orally once daily to subjects with Dyskinesia due to Cerebral Palsy (DCP)
- MedPacto MP-VAC-301 Metastatic Colorectal Cancer
- Pfizer Global Medical Grants Announces a New Education RFP in Pneumococcal Immunization
- Projects that will be considered for Pfizer support will focus on:
- Support educational programs that address knowledge gaps for health care providers in the updated adult pneumococcal immunization recommendations from the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP).
- Pfizer Global Medical Grants Announces a New Education RFP in Prostate Cancer
- Projects that will be considered for Pfizer support will focus on:
- Increasing the understanding of the mechanism of action, biological and clinical rationale for PARP-inhibitor combinations as potential treatments for prostate cancer.
- The evolving paradigm of the potential treatment of mCRPC with future PARP inhibitor combinations.
Please contact Scott Davis at firstname.lastname@example.org if you would like to receive more information on any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research Administration.
- Notice of NICHD Participation on PAR-21-358 " Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)"
- Notice of Clarification of Research Priorities for RFA-NR-22-002, "Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)"
- Notice Announcing FAQs, Webinar Recording, and Presentation for RFA-NR-22-001 "Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)"
- The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2022 SGM Research Investigator Awards Program
- Notice of Pre-Application Webinar and Availability of FAQs for RFA-OD-22-003, Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
- Notice of Pre-Application Webinar and Availability of FAQs for RFA-OD-22-004, Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
- Request for Information (RFI) on Capacity and Support Needed to Increase Community-Based Research Networks Participation in Alzheimers Disease and Related Dementias (AD/ADRD) Clinical Trials
- NIH Request for Information (RFI) on Interdisciplinary Research Opportunities that Bridge Neuroscience and Environmental Health Science
- Notice of Participation of the National Institute on Aging (NIA) in PAR-22-072 "Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)"
- Notice of Change to Eligibility Information in PAR-22-075, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
- Notice of Participation of the National Center for Complementary and Integrative Health (NCCIH) in PAR-21-173, "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
- Notice of Participation of the National Center for Complementary and Integrative Health (NCCIH) in PAR-21-169, "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Application Receipt Date(s): January 07, 2025
- NIA Program Project Applications (P01 Clinical Trial Optional)
Application Receipt Date(s): September 07, 2025
- NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
Application Receipt Date(s): May 07, 2025
- Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)
Application Receipt Date(s): August 03, 2022
- Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)
Application Receipt Date(s): July 06, 2022
- CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) (Clinical Trial Optional)
Application Receipt Date(s): July 27, 2022
- Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
Application Receipt Date(s): July 14, 2022
- Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
Application Receipt Date(s): July 14, 2022
Other Funding Opportunities
Harrington Discovery Institute Opens Call for 2023 Harrington Scholar-Innovator Award
Description: Harrington Discovery Institute at University Hospitals is now accepting Letters of Intent for the 2023 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants financial resources and expertise to advance their discoveries toward clinical trials. Intellectual property rights are retained by the award recipient or their institution.
Letter of Intent deadline: March 28, 2022. The full application deadline, for those invited to submit, is May 30, 2022.
Link to Full Announcement: Learn more and apply to the 2023 Scholar-Innovator Award at: HarringtonDiscovery.org/funding/harrington-scholar-innovator
Summer Research Training for Junior Faculty from Diverse Backgrounds
Description: The National Heart, Lung, and Blood Institute seeks pre-applications for its Programs to Increase Diversity Among Individuals Engaged in Health Related Research (PRIDE) initiative. PRIDE offers hands-on, mentored research lab experiences, small project awards for pilot research, and grant writing courses for junior faculty and transitioning post-doctoral candidates from diverse backgrounds. The goal is to increase diversity in the biomedical research workforce while enabling early career investigators to become competitive independent scientists.
Chosen applicants will have their training expenses fully covered for two consecutive summers. Training takes place at nine NHLBI-funded sites across the country, and each program is centered on a different area of heart, lung, blood, and sleep disorders research:
Pre-Applications Due: March 31, 2022
Link to Full Announcement: https://pridecc.wustl.edu/
HHS/CDC (Forecasted) Building Mathematical Modeling Workforce Capacity to Support Infectious Disease and Healthcare Research
Description: The purpose of this notice of funding opportunity is to support pre-doctoral fellows’ innovative research to develop and apply computational tools and mathematical methods for modeling the spread of pathogens in healthcare settings (e.g., SARS-CoV-2, healthcare-associated infections [HAIs], antimicrobial resistant organisms [AROs]). This NOFO is intended to increase the number of junior modeling professionals that are trained and experienced in modeling transmission of pathogens in healthcare settings and to contribute to generalizable scientific knowledge through dissemination (e.g., pre-prints, peer-reviewed studies, scientific presentations). The application should be written by the PI/mentor who may or may not name specific pre-doctoral student(s) to conduct the research at the time of application submission.
Estimated Application Due Date: May 04, 2022
Link to Full Announcement: https://www.grants.gov/web/grants/view-opportunity.html?oppId=337897
Robert Wood Johnson Foundation Funding Opportunities
The Robert Wood Johnson Foundation funds a wide array of research and initiatives to help address some of America’s most pressing health challenges.
The Interdisciplinary Research Leaders program seeks teams of researchers and community members committed to working together improve health equity by dismantling structural racism.
Application Due Date: Wed, 4 May 2022
Evidence for Action prioritizes research to evaluate specific interventions that have the potential to contribute to dismantling and counteracting the harms of structural and systemic racism and improving health, well-being, and equity outcomes.
Application Due Date: Proposals will be accepted throughout the year on a rolling admission
Pioneering Ideas: Exploring the Future to Build a Culture of Health welcomes proposals that are primed to influence health equity in the future.
Application Due Date: Proposals will be accepted throughout the year on a rolling admission
Link to Full Announcement: https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html
The International Center for Responsible Gaming (ICRG) 2022 Grants Program
Description: The ICRG awards grants on a competitive basis for a variety of research activities exploring the etiology, prevention and treatment of gambling disorder and the development and evaluation of responsible gambling strategies.
Large Grant: Up to $75,000/per year in direct costs for 2 years
Deadline for Letters of Intent: April 1, 2022
Application Deadline: June 30, 2022
Seed Grant: Up to $30,000/per year in direct costs for one year
Application Deadline: May 2, 2022
Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding
American Cancer Society – Institutional Research Grants
American Cancer Society – Health Equity Research
American Cancer Society – Discovery Boost Grants
Applications Due: April 1, 2022
Link to Full Announcements: https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/institutional-research-grants.html
Chan Zuckerberg Initiative - Scaling the CZ Biohub model to pursue the toughest and most important scientific challenges.
Description: A central goal of the CZ Biohub Network is to promote collaboration across disciplines and among institutions. To facilitate such collaboration, applications must be submitted jointly from at least three universities and/or other research institutions within the same city or geographic area. We expect that the next CZ Biohub will receive a 10-year funding commitment in the range of $200–250 million.
LOIs Due: April 1, 2022
Link to Full Announcement: https://www.czbiohub.org/cz-biohub-network-applications/
Southwest Center for Occupational and Environmental Health Pilot Projects Research Training Program
Description: The goal of the Pilot Projects Research Training Program is to enhance Southwest Center for Occupational and Environmental Health (SWCOEH) regional outreach efforts in research training and to foster stronger inter-institutional ties in occupational health research within Public Health Region 6 (PHR 6) (Arkansas, Louisiana, New Mexico, Oklahoma and Texas). The objective of this program is to provide a support mechanism for pilot research projects initiated by:
- Research Trainee Awards: Graduate doctoral students or postdoctoral fellows in an occupational health and safety-related discipline.
- Junior Investigator Awards: New investigators with research interests in the general area of occupational health and safety. Junior investigators are defined as faculty who have not served as PI on any Public Health Service (PHS)-supported research grants other than a R03, R15, R21, K01, K08, or K12.
- New Researcher Awards: Researcher or Faculty in areas other than occupational health research who wish to apply their expertise to an occupational safety and health issue.
LOIs Due: March 15, 2022
Full proposals Due: April 15, 2022
Link to Full Announcement: https://sph.uth.edu/research/centers/swcoeh/pilot-projects/
NIH technology accelerator challenge for maternal health
Description: The National Institute of Biomedical Imaging and Bioengineering (NIBIB), with the support of its partners, is offering up to $1,000,000 in cash prizes for innovative diagnostic technologies to help improve maternal health around the world.
The NIH Technology Accelerator Challenge for Maternal Health (NTAC: Maternal Health) seeks to spur and reward the development of prototypes for low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality.
To win NTAC: Maternal Health, participants must: (1) Submit their design for a point-of-care diagnostic test or platform technology with initial feasibility data or references addressing at least two of the four priority conditions listed below affecting maternal health during antenatal and intrapartum periods; and (2) Submit a robust description of the proposed path for translation and further development of the diagnostic technology for use in global health settings. Additionally, diagnostics should be fully integrated digital health platforms. The four priority conditions and specific examples are as follows:
- Infection: viral, bacterial, or parasitic infections; sepsis; post-procedural infections
- Hypertensive disease: pre-eclampsia; eclampsia
- Hemorrhage: acute anemia; iron deficiency anemia; coagulopathy
- Placental issues: angiogenic or other markers of placental disruption
Proposals Due: April 1, 2022
Link to Full Announcement: https://venturewell.org/ntac/
Cystic Fibrosis Foundation
Clinical Research Award - Letter of Intent: March 28, 2022; Full application: August 8, 2022
The International Foundation for Ethical Research (IFER) – 2022-2023 GRADUATE FELLOWSHIPS FOR ALTERNATIVES TO THE USE OF ANIMALS IN SCIENCE
Description: IFER Graduate Fellowships are one-year grants for projects that support the development, acceptance and implementation of innovative scientific methodologies that advance science and refine, reduce or replace the use of animals in research, testing or education. Grants of $12,500 are typically awarded and are renewable annually for up to three years, depending on student progress and availability of funds. IFER recognizes the value in directing financial resources away from animal models and toward the development of human-relevant, non-animal models, as such resources pay higher dividends for human health when used for human-relevant research.
Pre-proposals Due: April 30, 2022
Link to Full Announcement: More information on the IFER Graduate Fellowship program, including eligibility requirements, submission guidelines, and a link to the online application can be found on the IFER website at www.ifer.org/fellowships.php.
Melanoma Research Alliance (MRA) Dermatology Fellowship & Junior Faculty Awards
Description: The aim of this training program is to drive greater interest and focus on melanoma in dermatologic clinical practice and research related to the prevention, detection, diagnosis, and staging of melanoma.
- MRA Dermatology Fellows Award – Supports dermatology residents, fellows, or post-docs in a dermatology program with research, and/or demonstration and pilot programs focused on melanoma prevention or improving early detection, diagnosis, or prognosis.
- MRA Dermatology Junior Faculty/Clinical Instructor Award - Supports new dermatology
faculty (clinical instructors or new assistant professors) working in research on melanoma
prevention or improving early detection, diagnosis, or prognosis.
Proposals Due: April 20, 2022
Link to Full Announcement: https://www.curemelanoma.org/research/request-for-proposals/dermatology-fellows-award